You are here

lovo-cel

Bluebird’s Lovo-Cel Gene Therapy for SCD Will Not Face FDA Adcomm

Bluebird’s Lovo-Cel Gene Therapy for SCD Will Not Face FDA Adcomm

BioSpace

sickle cell disease

Flag link:

Bluebird, playing catch-up, gets decision date for sickle cell gene therapy

Bluebird, playing catch-up, gets decision date for sickle cell gene therapy

BioPharma Dive

sickle cell disease

Flag link:

Bluebird Bio submits BLA for sickle cell disease gene therapy

Bluebird Bio submits BLA for sickle cell disease gene therapy

Biopharma Reporter

sickle cell disease

Flag link:

Bluebird to miss Q1 deadline for lovo-cel filing, shares sliced

Bluebird to miss Q1 deadline for lovo-cel filing, shares sliced

Endpoints

sickle cell disease

Flag link:

FDA Lifts Partial Clinical Hold On Bluebird Bio's Sickle Cell Disease Studies

FDA Lifts Partial Clinical Hold On Bluebird Bio's Sickle Cell Disease Studies

NASDAQ

clinical trials

sickle cell disease

Flag link:

ASH: Despite partial clinical hold, bluebird's sickle cell gene therapy remains on track

ASH: Despite partial clinical hold, bluebird's sickle cell gene therapy remains on track

Fierce Pharma

sickle cell disease

Flag link:

bluebird says future uncertain as delays to gene therapies bite

bluebird says future uncertain as delays to gene therapies bite

Pharmaforum

Flag link:

bluebird bio Announces Partial Clinical Hold for Patients Under 18 in Sickle Cell Gene Therapy Clinical Program

bluebird bio Announces Partial Clinical Hold for Patients Under 18 in Sickle Cell Gene Therapy Clinical Program

Yahoo Finance

sickle cell disease

clinical trials

Flag link: